Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
EVFM [NASD]
Evofem Biosciences, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-2.34 Insider Own2.20% Shs Outstand81.84M Perf Week-12.00%
Market Cap95.04M Forward P/E- EPS next Y-0.96 Insider Trans9.26% Shs Float81.07M Perf Month27.91%
Income-169.30M PEG- EPS next Q-0.41 Inst Own41.60% Short Float13.35% Perf Quarter-58.96%
Sales1.60M P/S59.40 EPS this Y-6.50% Inst Trans35.25% Short Ratio0.92 Perf Half Y-46.86%
Book/sh-0.17 P/B- EPS next Y40.70% ROA-150.20% Target Price- Perf Year-62.46%
Cash/sh- P/C- EPS next 5Y- ROE-702.10% 52W Range0.75 - 5.53 Perf YTD-54.36%
Dividend- P/FCF- EPS past 5Y35.40% ROI-131.30% 52W High-80.11% Beta-0.33
Dividend %- Quick Ratio0.90 Sales past 5Y- Gross Margin37.20% 52W Low46.47% ATR0.12
Employees147 Current Ratio1.10 Sales Q/Q- Oper. Margin- RSI (14)49.04 Volatility12.44% 8.31%
OptionableYes Debt/Eq- EPS Q/Q-41.90% Profit Margin- Rel Volume1.33 Prev Close1.16
ShortableYes LT Debt/Eq- EarningsMay 06 AMC Payout- Avg Volume11.72M Price1.10
Recom2.00 SMA2012.96% SMA50-10.81% SMA200-52.44% Volume15,554,400 Change-5.17%
Oct-02-20Initiated Stifel Buy $5
Aug-20-20Initiated Morgan Stanley Equal-Weight $3
Jun-08-20Initiated Piper Sandler Overweight $11
Oct-16-19Resumed Cantor Fitzgerald Overweight $9
Jun-01-21 09:00AM  
Evofem Biosciences to Present at Jefferies Virtual Healthcare Conference 2021
PR Newswire
May-25-21 08:00AM  
Evofem Biosciences to Present at LD Micro Invitational XI on Tuesday, June 8, 2021
PR Newswire
May-21-21 06:50AM  
Evofem Biosciences Announces Closing of $50 Million Public Offering
PR Newswire
May-18-21 09:06AM  
Evofem Biosciences Stock Plunges On Raising $50M Via Equity At 22% Discount
Benzinga -34.17%
May-17-21 11:02PM  
Evofem Biosciences Announces Pricing of $50 Million Public Offering
PR Newswire
04:02PM  
Evofem Biosciences Announces Proposed Public Offering
PR Newswire
08:00AM  
New Data on EVO100 for the Prevention of Chlamydia and Gonorrhea in Women to be Presented at ISPOR 2021
PR Newswire
May-12-21 04:19PM  
Fulcrum Therapeutics, Evofem Biosciences Drug Candidates Receive FDA Fast Track Designation
Benzinga
09:00AM  
Evofem Biosciences Receives Fast Track Designation for EVO100 for Prevention of Gonorrhea in Women
PR Newswire
May-06-21 04:01PM  
Evofem Biosciences Reports First Quarter 2021 Financial Results and Provides Corporate Update
PR Newswire -5.43%
02:30PM  
Evofem Biosciences, Inc. to Host Earnings Call
ACCESSWIRE
Apr-28-21 11:00AM  
Evofem Biosciences Announces Presentation of Two New Phexxi Data Sets at the 2021 American College of Obstetricians and Gynecologists Annual Meeting
PR Newswire
Apr-22-21 08:00AM  
Evofem Biosciences to Report First Quarter 2021 Results and Provide Corporate Update on Thursday, May 6, 2021
PR Newswire
Apr-21-21 08:00AM  
Evofem Biosciences to Deliver Keynote Address and Present Two Phexxi Data Sets at NCODA 2021 National Spring Forum
PR Newswire +10.56%
Mar-29-21 04:05PM  
Evofem Biosciences Announces Closing of Public Offering of Common Stock
PR Newswire -6.42%
Mar-25-21 07:58AM  
The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut
Benzinga -26.61%
Mar-24-21 10:00PM  
Evofem Biosciences Announces Pricing of $30 Million Public Offering of Common Stock
PR Newswire -9.34%
04:00PM  
Evofem Biosciences Announces Proposed Public Offering of Common Stock
PR Newswire
Mar-17-21 08:00AM  
Evofem Biosciences' DTC Campaign "Get Phexxi" Delivers Strong Initial Impact
PR Newswire
Mar-16-21 08:00AM  
Evofem Biosciences Announces Publication in American Journal of Obstetrics and Gynecology of AMPREVENCE Study of EVO100 for Chlamydia and Gonorrhea Prevention
PR Newswire
Mar-06-21 03:05AM  
What Type Of Shareholders Make Up Evofem Biosciences, Inc.'s (NASDAQ:EVFM) Share Registry?
Simply Wall St.
Mar-05-21 01:00PM  
Why Evofem Biosciences Stock Is Falling Today
Motley Fool -30.28%
10:38AM  
ROCE Insights For Evofem Biosciences
Benzinga
Mar-04-21 04:00PM  
Evofem Biosciences Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
PR Newswire -9.17%
02:30PM  
Evofem Biosciences, Inc. to Host Earnings Call
ACCESSWIRE
Feb-23-21 08:00AM  
Evofem Biosciences to Present at H.C. Wainwright Global Life Sciences Conference
PR Newswire -7.88%
Feb-18-21 08:00AM  
Evofem Biosciences to Report Fourth Quarter and Year-End 2020 Results and Provide Corporate Update on Thursday, March 4, 2021
PR Newswire
Feb-16-21 08:00AM  
Evofem Biosciences Launches U.S. Direct-to-Consumer Campaign to Accelerate Awareness of Phexxi®, A Non-Hormonal Birth Control Option for Women
PR Newswire
Feb-04-21 09:00AM  
Evofem Biosciences and NCODA Announce Collaboration to Educate Oncology Community about Phexxi®, A Non-Hormonal Birth Control Option for Women with Cancer
PR Newswire +6.15%
Jan-12-21 09:05AM  
Evofem Biosciences Wins Business Intelligence Group's BIG Innovation Award 2021
PR Newswire
Dec-22-20 07:00AM  
Evofem Biosciences to Participate in Medicaid National Drug Rebate Program for Phexxi® Effective January 1, 2021
PR Newswire +12.56%
Dec-21-20 09:00AM  
Evofem Biosciences to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
PR Newswire
Dec-17-20 07:00AM  
Evofem Biosciences Provides Update on Pivotal Phase 3 Trial of EVO100 for Prevention of Chlamydia and Gonorrhea
PR Newswire
Dec-12-20 03:12PM  
Is EVFM A Good Stock To Buy Now?
Insider Monkey
Dec-11-20 08:00AM  
Evofem Biosciences Announces Orange Book Listing of Two U.S. Patents for Phexxi®
PR Newswire
Dec-03-20 07:00AM  
The U.S. Department of Veterans Affairs Awards Contract to Evofem Biosciences for Phexxi®
PR Newswire
Nov-20-20 08:30AM  
Evofem Biosciences to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference
PR Newswire
Nov-12-20 08:30AM  
Evofem Biosciences to Present at Stifel Virtual Healthcare Conference
PR Newswire
Nov-09-20 11:00PM  
Evofem Biosciences, Inc. (EVFM) Q3 2020 Earnings Call Transcript
Motley Fool
04:01PM  
Evofem Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Update
PR Newswire
03:15PM  
Evofem Biosciences, Inc. to Host Earnings Call
ACCESSWIRE
Oct-27-20 08:00AM  
Evofem Biosciences to Report Third Quarter 2020 Results and Provide Corporate Update on Monday, November 9, 2020
PR Newswire
Oct-26-20 09:00AM  
Evofem Biosciences to Participate in Virtual Investor KOL Roundtable
PR Newswire
Oct-20-20 08:00AM  
Evofem Biosciences Announces First Patient Enrolled in Pivotal Phase 3 Trial of EVO100 for Prevention of Chlamydia and Gonorrhea
PR Newswire -6.38%
Oct-08-20 10:15AM  
Unusual Options Activity Insight: Evofem Biosciences
Benzinga
Oct-07-20 08:00AM  
Evofem Biosciences Announces Presentations on Phexxi and EVO100 at Key Medical Society Meetings
PR Newswire +5.19%
Sep-16-20 12:13PM  
Evofem Biosciences Announces Updated Date and Time for Fireside Chat at Cantor Global Virtual Healthcare Conference
PR Newswire
Sep-14-20 09:42AM  
Is the Options Market Predicting a Spike in Evofem Biosciences (EVFM) Stock?
Zacks +11.90%
09:00AM  
Evofem Biosciences to Present Data at the 2020 STD Prevention Virtual Conference from Phase 2b Trial of EVO100 for Prevention of Chlamydia and Gonorrhea in Women
PR Newswire
Sep-11-20 12:02PM  
Why Evofem Biosciences Stock Is Plunging Today
Motley Fool -22.79%
10:27AM  
Return On Capital Employed Overview: Evofem Biosciences
Benzinga
Sep-07-20 11:57AM  
What Is The Ownership Structure Like For Evofem Biosciences, Inc. (NASDAQ:EVFM)?
Simply Wall St.
Aug-31-20 09:00AM  
Evofem Biosciences to Participate in Four Upcoming Investor Conferences
PR Newswire +6.07%
Aug-21-20 06:00PM  
Evofem Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Aug-20-20 09:51AM  
Benzinga's Top Upgrades, Downgrades For August 20, 2020
Benzinga
Aug-11-20 08:53AM  
Do Options Traders Know Something About Evofem Biosciences (EVFM) Stock We Don't?
Zacks
Aug-04-20 09:31PM  
Evofem Biosciences, Inc. (EVFM) Q2 2020 Earnings Call Transcript
Motley Fool -5.63%
08:00AM  
Evofem Biosciences Reports Second Quarter 2020 Financial Results and Provides Corporate Update
PR Newswire
Aug-03-20 08:30AM  
Evofem Biosciences' CEO Saundra Pelletier Named to PharmaVOICE100 - The Most Inspiring People in Life Sciences
PR Newswire +7.02%
Jul-23-20 08:30AM  
Evofem Biosciences to Report Second Quarter 2020 Results and Provide Corporate Update on Tuesday, August 4, 2020
PR Newswire
Jul-21-20 03:55AM  
Edited Transcript of EVFM.OQ earnings conference call or presentation 6-Aug-19 3:00pm GMT
Thomson Reuters StreetEvents
03:55AM  
Edited Transcript of EVFM.OQ earnings conference call or presentation 7-Nov-19 4:00pm GMT
Thomson Reuters StreetEvents
Jul-15-20 08:30AM  
Evofem Biosciences Announces Peer-Reviewed Publication of the Pivotal Phase 3 AMPOWER Study Results For Phexxi (lactic acid, citric acid and potassium bitartrate) in Contraception
PR Newswire
Jul-01-20 08:01AM  
Evofem Biosciences Issues Mid-Year 2020 Letter to Stockholders
PR Newswire +8.48%
Jun-29-20 09:33AM  
Are Options Traders Betting on a Big Move in Evofem Biosciences (EVFM) Stock?
Zacks
Jun-26-20 08:44AM  
Evofem Biosciences (EVFM) Looks Good: Stock Adds 10.1% in Session
Zacks -5.56%
Jun-12-20 08:08AM  
Edited Transcript of EVFM earnings conference call or presentation 6-May-20 3:00pm GMT
Thomson Reuters StreetEvents
Jun-03-20 12:31PM  
Why Evofem Biosciences Is Down Today
Motley Fool -26.61%
Jun-02-20 11:03PM  
Evofem Announces Pricing of Approximately $100 Million Public Offering of Common Stock
PR Newswire -7.91%
04:01PM  
Evofem Announces Proposed Public Offering of Common Stock
PR Newswire
May-31-20 05:15PM  
Is Evofem Biosciences, Inc. (EVFM) A Good Buy According To Hedge Funds?
Insider Monkey
May-28-20 06:30AM  
Finally, Some Good News for Evofem Biosciences
Motley Fool -6.75%
May-27-20 10:56AM  
Company News for May 27, 2020
Zacks
08:55AM  
Are Options Traders Betting on a Big Move in Evofem Biosciences (EVFM) Stock?
Zacks
May-26-20 10:32AM  
A Look Into Evofem Biosciences' Price Over Earnings
Benzinga +16.03%
09:52AM  
Evofem Biosciences Soars as Birth-Control Gel Receives FDA OK
TheStreet.com
09:00AM  
Why Evofem Biosciences Stock Is on Fire Today
Motley Fool
08:42AM  
Evofem Biosciences Rallies on Contraceptive Gel Approval: What's Next?
TheStreet.com
May-22-20 04:37PM  
Evofem stock rallies as FDA approves birth-control gel
MarketWatch
04:05PM  
U.S. FDA Approves Evofem Biosciences' Phexxi (lactic acid, citric acid and potassium bitartrate), the First and Only Non-Hormonal Prescription Gel for the Prevention of Pregnancy
PR Newswire
01:09PM  
Birth Control Gel Approved as First No-Hormone Option in Decades
Bloomberg
01:07PM  
Evofem's gel first non-hormonal contraceptive to get approval in over 30 years
Reuters
01:07PM  
Evofem non-hormonal birth control gel gets FDA approval, to be priced at up to $275
Reuters
May-21-20 04:05PM  
PDL BioPharma Completes Distribution of Evofem Biosciences Common Stock to PDL Stockholders
PR Newswire
May-18-20 04:05PM  
PDL BioPharma Declares Distribution Ratio for Dividend of Evofem Biosciences Common Stock to PDL Stockholders
PR Newswire
May-13-20 08:00AM  
Evofem Biosciences to Participate in Virtual Fireside Chat at RBC Capital Markets Global Healthcare Conference
PR Newswire
May-08-20 09:00AM  
PDL Biopharma Inc (PDLI) Q1 2020 Earnings Call Transcript
Motley Fool
May-07-20 07:30AM  
Evofem Biosciences, Inc. (EVFM) Q1 2020 Earnings Call Transcript
Motley Fool
May-06-20 08:00AM  
Evofem Biosciences Reports First Quarter 2020 Financial Results and Provides Corporate Update
PR Newswire
May-01-20 05:21PM  
Evofem Biosciences Announces New Location and COVID-19 Preventative Measures for 2020 Annual Meeting Scheduled for May 12, 2020
PR Newswire +5.49%
Apr-28-20 08:00AM  
Evofem Biosciences to Report First Quarter 2020 Results and Provide Corporate Update on Wednesday, May 6, 2020
PR Newswire -7.50%
Apr-24-20 08:30AM  
Evofem Biosciences Announces Three New Phexxi Data Sets Accepted for Presentation at the 2020 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting
PR Newswire
Apr-19-20 07:02AM  
3 Top Biotech Stocks with FDA Approvals on the Horizon
TipRanks
Apr-10-20 04:05PM  
Evofem Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire
Mar-30-20 05:14PM  
Edited Transcript of EVFM earnings conference call or presentation 12-Mar-20 3:00pm GMT
Thomson Reuters StreetEvents +7.96%
Mar-27-20 08:30AM  
Evofem Biosciences to Present at Solebury Trout Virtual Investor Conference
PR Newswire
Mar-25-20 05:00PM  
Evofem Biosciences Adopts Shareholder Rights Agreement
PR Newswire
Mar-24-20 04:00PM  
Solebury Trout Announces Virtual Conference Series with Presentations from Life Science Companies
ACCESSWIRE +11.05%
Mar-19-20 08:15AM  
TRACON Pharmaceuticals Announces Appointment of Saundra Pelletier to Board of Directors
GlobeNewswire +11.90%
Mar-12-20 09:00AM  
Evofem Biosciences, Inc. to Host Earnings Call
ACCESSWIRE -23.06%
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. It has a collaboration agreement with National Community Oncology Dispensing Association, Inc. to educate oncology community about Phexxi. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
O'Brien Anthony StephenDirectorJun 14Buy1.318,14010,6638,140Jun 14 04:13 PM
Rarick Lisa DaleDirectorJun 11Buy1.205,0005,99010,250Jun 14 04:14 PM
Barrans RussellChief Commercial OfficerJun 11Buy1.1418,18020,725468,552Jun 11 08:19 PM
File Justin J.Chief Financial OfficerJun 10Buy1.0324,50025,235440,388Jun 10 07:30 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryJun 10Buy1.0210,00010,250311,422Jun 10 07:29 PM
PELLETIER SAUNDRA LChief Executive OfficerJun 10Buy1.0350,00051,500850,837Jun 10 07:30 PM
PELLETIER SAUNDRA LChief Executive OfficerMar 09Buy2.2845,249103,168906,137Mar 09 06:59 PM
File Justin J.Chief Financial OfficerNov 17Buy2.177,76016,839258,168Nov 18 05:22 PM
Fitzpatrick Alexander AGeneral Counsel and SecretaryNov 17Buy2.209,09019,998143,542Nov 18 05:14 PM
Barrans RussellChief Commercial OfficerSep 11Buy2.083,0006,240279,052Sep 11 05:20 PM
Barrans RussellChief Commercial OfficerSep 10Buy2.711,0002,710276,052Sep 11 05:20 PM
PELLETIER SAUNDRA LChief Executive OfficerSep 08Sale3.26122,500399,350360,888Sep 10 08:04 PM
open in yahoo | open in reuters | open in marketwatch | open in google
affiliate • advertise • contact • privacy • help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2021 FINVIZ.com. All Rights Reserved.